Bouaziz et al. suggest that TLR9 is protective against atherosclerosis. In vitro activation of TLR9 stimulates interleukin-10 (IL-10) production, which in turn inhibits the INF-α secretion by plasma dendritic cells and CD4+ CD25+ T-cell proliferation [67]. The gene discussed is IL10; the disease is atherosclerosis.